In addition, high levels of KAT6A significantly correlate with reduced relapse‐free survival (RFS) in the basal clinical breast cancer samples in the Kaplan–Meier Plotter dataset (https://kmplot.com/analysis) (Figure 1C). This evidence concerns the gene KAT6A and breast carcinoma.